PCSA: Processa Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PCSA: Processa Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.21
Enterprise Value ($M) -1.69
Book Value ($M) 3.53
Book Value / Share 0.67
Price / Book 0.34
NCAV ($M) 2.47
NCAV / Share 0.47
Price / NCAV 0.49

Profitability (mra)
Return on Invested Capital (ROIC) -3.34
Return on Assets (ROA) -1.20
Return on Equity (ROE) -1.35

Liquidity (mrq)
Quick Ratio 2.93
Current Ratio 2.93

Balance Sheet (mrq) ($M)
Current Assets 3.76
Assets 4.81
Liabilities 1.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.05
Net Income -11.85
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Warrants n/a
Earnings Per Share Common Shares Issued And Outstanding Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Common Shares Issued And Outstanding Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.25
Cash from Investing -0.00
Cash from Financing 7.73

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-30 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 182,802 620,146 29.48
2025-05-12 440,770 852,125 51.73
2025-05-09 580,204 1,616,785 35.89
2025-05-08 538,624 1,632,853 32.99

(click for more detail)

Similar Companies
OTLK – Outlook Therapeutics, Inc. PALI – Palisade Bio, Inc.
PASG – Passage Bio, Inc. PDSB – PDS Biotechnology Corporation
PHIO – Phio Pharmaceuticals Corp.


Financial data and stock pages provided by
Fintel.io